Tomlinson Ashley N, Skinner Debra, Perry Denise L, Scollon Sarah R, Roche Myra I, Bernhardt Barbara A
Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
FPG Child Development Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
J Genet Couns. 2016 Feb;25(1):62-72. doi: 10.1007/s10897-015-9842-8. Epub 2015 Apr 26.
As the use of genomic technology has expanded in research and clinical settings, issues surrounding informed consent for genome and exome sequencing have surfaced. Despite the importance of informed consent, little is known about the specific challenges that professionals encounter when consenting patients or research participants for genomic sequencing. We interviewed 29 genetic counselors and research coordinators with considerable experience obtaining informed consent for genomic sequencing to understand their experiences and perspectives. As part of this interview, 24 interviewees discussed an informed consent case they found particularly memorable or challenging. We analyzed these case examples to determine the primary issue or challenge represented by each case. Challenges fell into two domains: participant understanding, and facilitating decisions about testing or research participation. Challenges related to participant understanding included varying levels of general and genomic literacy, difficulty managing participant expectations, and contextual factors that impeded participant understanding. Challenges related to facilitating decision-making included complicated family dynamics such as disagreement or coercion, situations in which it was unclear whether sequencing research would be a good use of participant time or resources, and situations in which the professional experienced disagreement or discomfort with participant decisions. The issues highlighted in these case examples are instructive in preparing genetics professionals to obtain informed consent for genomic sequencing.
随着基因组技术在研究和临床环境中的应用不断扩展,围绕基因组和外显子组测序的知情同意问题浮出水面。尽管知情同意很重要,但对于专业人员在为患者或研究参与者进行基因组测序的知情同意过程中遇到的具体挑战,我们却知之甚少。我们采访了29位在获取基因组测序知情同意方面有丰富经验的遗传咨询师和研究协调员,以了解他们的经历和观点。作为此次采访的一部分,24位受访者讨论了一个他们认为特别难忘或具有挑战性的知情同意案例。我们分析了这些案例,以确定每个案例所代表的主要问题或挑战。挑战主要分为两个方面:参与者的理解,以及促进关于检测或参与研究的决策。与参与者理解相关的挑战包括不同水平的一般知识和基因组知识、难以管理参与者的期望,以及阻碍参与者理解的背景因素。与促进决策相关的挑战包括复杂的家庭关系,如分歧或胁迫、不清楚测序研究是否会有效利用参与者的时间或资源的情况,以及专业人员对参与者的决定存在分歧或感到不适的情况。这些案例中突出的问题对于让遗传学专业人员为基因组测序获取知情同意具有指导意义。